Company news
Boundless Bio, Inc. news in 2024
Boundless Bio, Inc.'s news releases, calls and decks from 2024, newest first.
Boundless Bio Announces Pipeline and Leadership Updates
December 11, 2024
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
November 6, 2024
Boundless Bio Announces Departure of Chief Financial Officer
October 13, 2024
Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results
August 11, 2024
Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights
May 12, 2024
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
April 10, 2024
Boundless Bio Announces Pricing of Initial Public Offering
March 26, 2024